Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877
Published June 9, 2021 · Recall initiated: May 4, 2021
Summary
FDA records drug Class II recall D-0600-2021, published June 9, 2021 and initiated May 4, 2021. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 15,198 bottles (30 tablets per bottle); Lot: Lot #860412; SEPT 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Distributor
- AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR
- Lot
- Lot #860412; SEPT 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60July 8, 2026
- FDAJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDCMarch 29, 2023
- FDAThiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) perJune 9, 2021
- FDANPr FCZ®Imp Crwn ASC CC RP CAD 1-25® s4 - Product Usage: Implant Crown intended to be placed in the upper orJune 2, 2021
- FDACatapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
- FDACatapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
Questions about this recall
Was Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 recalled?
Yes. FDA published recall D-0600-2021 on June 9, 2021. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter